Sean McElligott, MS

Business of Pathways

Health Care as a Preexisting Financial Condition: Individual Costs and Societal Benefits

12/17/2019

While societally we are still debating the best way to finance health care, we do all agree that when a therapy is available to alleviate illness and suffering, we should find a way to make it available to patients....

While...

12/17/2019

Journal of Clinical Pathways

Business of Pathways

Broadening the Value Assessment Paradigm: Including the Value of Hope and the Value of Insurance

10/18/2019

Sean McElligott , MS;

Ira Klein , MD, MBA, FACP;

*/ /*-->*/ While social media is all about sharing, very little personal preference data makes its way into health plan contracting around specific interventions and pathway programs today. As a result, the...

...

10/18/2019

Journal of Clinical Pathways

Business of Pathways

Cell and Gene Therapies: Paying It Forward and Adjusting Payment Systems for the Age of Cures

06/18/2019

Ira Klein , MD, MBA, FACP;

Sean McElligott , MS;

Cell and gene therapies represent the next frontier of pharmaceutical development, holding the promise of delivering potentially curative therapies for diseases that have limited treatment options. However, these...

Cell...

06/18/2019

Journal of Clinical Pathways